Sc China Holding LTD Zai Lab LTD Transaction History

Sc China Holding LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$126.27 - $191.71 $43.5 Million - $66 Million	-344,474 Reduced 33.15%	694,634 $92.7 Million
Q1 2020 May 15, 2020	SELL	$39.1 - $62.9 $39.1 Million - $62.9 Million	-1,000,001 Reduced 49.04%	1,039,108 $53.5 Million
Q3 2019 Nov 14, 2019	SELL	$30.47 - $37.65 $26.6 Million - $32.9 Million	-873,905 Reduced 30.0%	2,039,109 $66 Million
Q2 2019 Aug 14, 2019	BUY	$25.73 - $35.79 $75 Million - $104 Million	2,913,014 New	2,913,014 $102 Million

152

32.7M

168K

222K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.13B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Sc China Holding LTD, based on Form 13F filings with the SEC.

Stay updated on Sc China Holding LTD with notifications on news.